Back to Emergency Medicine
Emergency Medicinev2017Evidence-Based

ALT-70 Score for Cellulitis

Predicts likelihood of lower extremity cellulitis over other diagnoses (pseudocellulitis). Helps differentiate true cellulitis from its mimics in adult patients presenting to the emergency department with a red leg and clinical concern for cellulitis.

Clinical Input Parameters

Clinical Assessment
Awaiting Parameters
alt 70 score
—points
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The ALT-70 Score for Cellulitis is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within emergency medicine.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

ALT-70 Score = (3 × Asymmetric) + (1 × Leukocytosis) + (1 × Tachycardia) + (2 × Age ≥70)

Clinical Pearls & Practice Notes

  • Exclusion criteria: Do not use if patient has visible abscess/fluctuance, penetrating trauma, burn, diabetic ulcer, hardware/device, post-operative patient (surgery within 30 days), recent (within 48 hrs) IV antibiotic use, or known history of osteomyelitis
  • The ALT-70 score was developed and validated in emergency department settings and may not apply to primary care or other clinical settings
  • A score of 3-4 is considered indeterminate; consultation with dermatology or infectious disease is recommended for these patients
  • About 30% of patients admitted to the hospital for cellulitis are misdiagnosed, leading to unnecessary hospitalizations and antibiotic use
  • Common mimics of cellulitis include venous stasis dermatitis, contact dermatitis, superficial thrombophlebitis, gout, lymphedema, and more serious conditions like DVT or necrotizing fasciitis

Evidence & Literature Citations

  1. Raff AB, Weng QY, Cohen JM, Gunasekera N, Okhovat JP, Vedak P, et al. A predictive model for diagnosis of lower extremity cellulitis: a cross-sectional study. J Am Acad Dermatol. 2017 Apr;76(4):618-625.e2. doi: 10.1016/j.jaad.2016.12.044.
  2. Li DG, Dewan AK, Xia FD, Khosravi H, Joyce C, Mostaghimi A. The ALT-70 predictive model outperforms thermal imaging for the diagnosis of lower extremity cellulitis: a prospective evaluation. J Am Acad Dermatol. 2018 Dec;79(6):1076-1080.e1. doi: 10.1016/j.jaad.2018.06.062.
  3. Singer S, Li DG, Gunasekera N, Okhovat JP, Vedak P, Weng C, et al. The ALT-70 cellulitis model maintains predictive value at 24 and 48 hours after presentation. J Am Acad Dermatol. 2019 Dec;81(6):1252-1256. doi: 10.1016/j.jaad.2019.04.008.
  4. Weng QY, Raff AB, Cohen JM, Gunasekera N, Okhovat JP, Vedak P, et al. Costs and Consequences Associated With Misdiagnosed Lower Extremity Cellulitis. JAMA Dermatol. 2017 Feb 1;153(2):141-146. doi: 10.1001/jamadermatol.2016.3816.

Score Interpretation Ranges

Cellulitis Unlikely0 – 2 pts

Low probability of cellulitis

Indeterminate3 – 4 pts

Moderate probability of cellulitis

Cellulitis Likely5 – 7 pts

High probability of cellulitis

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.